All articles tagged: Chlamydial infection, unspecified (A74.9)
HealthDay
27 June at 11.14 AM
Ignorance Could Be Fueling Rising Spread of STDs, Poll FindsMany sexually transmitted diseases are on the rise in the United States, and a nationwide poll indicates that ignorance about how they're transmitted could be fueling their spread.About a third of Americans (34%) falsely believe sexually transmitted infections (<a href="https://www.healthday.com/a-to-z-health/infectious-diseases/most-common-st |
Evalytics
15 April at 05.51 PM
Chlamydia vaccine shows promise in early trialA chlamydia vaccine in early trials shows promise, offering hope for combating the prevalent sexually transmitted infection. The vaccine demonstrated effectiveness and safety in its initial testing phase. Further research is needed to assess its long-term efficacy and potential for widespread use. |
|
HealthDay
21 December at 04.13 PM
Doxycycline Postexposure Prophylaxis Does Not Avert STIs in WomenFor Kenyan women receiving preexposure prophylaxis against HIV, the incidence of sexually transmitted infections (STIs) does not differ for those receiving doxycycline postexposure prophylaxis (PEP) compared with standard care, according to a study published in the Dec. 21 issue of the New England Journal of Medicine.Jenell Stewart, D |
|
Evalytics
05 December at 06.22 PM
Pathogens use force to breach immune defenses, study findsIndiana University researchers have uncovered a new method pathogens use to breach the body's immune defenses. Instead of releasing chemical substances, some pathogens apply physical force during entry into host cells, allowing them to evade degradation. This finding offers a potential breakthrough in combating intracellular infections like tuberculosis, malaria, and chlamydia by targeting pathoge |
|
Evalytics
27 November at 05.37 PM
Will first FDA-approved at-home test for gonorrhea, chlamydia ease the epidemic?The FDA approved the first at-home test for chlamydia and gonorrhea, a significant step in addressing rising STI rates in the U.S. However, concerns about increased regulation potentially affecting availability and cost, and the test's limitations in covering all needs, particularly for syphilis and in the gay and bisexual community, remain points of debate. |
|
HealthDay
16 November at 09.53 PM
First OTC Test for Chlamydia, Gonorrhea Approved by the FDAOn Wednesday, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple 2 Test, the first home test for chlamydia and gonorrhea.People will be able to buy the Simple 2 Test over-the-counter at a pharmacy, take a specimen at home, and send their sample to a designated laboratory for testing, the FDA |
|
HealthDay
22 November at 04.44 PM
Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use DisorderSemaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from |
Medpage Today
17 November at 10.31 PM
Two Treatments That Don't Work for OsteoarthritisWASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... |
MedScape
11 November at 07.56 AM
Scoring System Could Mean Better Access to Lung TransplantScoring system could improve access for hard-to-match candidates due to height and blood type. |
Medical xPress
07 November at 07.50 AM
How key results could influence health policyThe results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. |
|
Medpage Today
05 November at 07.00 PM
Mpox Cases in Congo May Be StabilizingGOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... |
|
Medical xPress
02 November at 07.40 AM
Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study findsRutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. |
|
|
MedScape
31 October at 06.30 AM
Report: Rethink Race-Based Adjustments in Clinical ToolsThe slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. |
|
Medpage Today
25 October at 02.09 PM
Patients More Satisfied With AI's Answers Than Those From Their DoctorPatients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their clinician, according to a study in JAMA Network Open... |
|
Medical xPress
25 October at 12.40 PM
Surgical innovation: The intelligent turbine insufflatorThe Politecnico di Milano and the Erasmus Medical Center in Rotterdam have pooled their medical and technical expertise to create a new technology for devices called "insufflators." These innovative instruments are designed to create a temporary cavity in the bodies of patients through the application of pressurized gas, providing the surgeon with the necessary space to perform the surgical proced |
|
Medical xPress
24 October at 07.50 AM
Genetic variants in melatonin receptor linked to idiopathic osteoporosisColumbia University Medical Center researchers have identified specific variants in a melatonin receptor gene that impair bone turnover, leading to significant reductions in bone density and increased risk of fractures, particularly in Ashkenazi Jewish individuals. |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
